News
Leader in the development, production and
commercialisation of pharmacogenetics tests
for cancer precision medicine.
2005, 2025
UGT1A1 & DPYD: Safer chemotherapy starts with genotyping
DPYD Genotyping in Fluoropyrimidine Therapy: Reducing Toxicity, Improving Outcome [...]
805, 2025
Advancing Precision Medicine: Preventing ADRs with Pharmacogenomic Panel Testing
Drug response is highly variable between individuals. This interindividual [...]
2304, 2025
Diatech Pharmacogenetics will attend the SEAP-IAP 2025 Congess
We are excited to share that Diatech Pharmacogenetics will [...]
901, 2025
Diatech Pharmacogenetics will exhibit at Medlab-Middle East from February 3 to 6 in Dubai
Diatech Pharmacogenetics will exhibit at Medlab, a landmark event [...]
2012, 2024
Diatech Pharmacogenetics wishes you a wonderful Festive Season!
Diatech Pharmacogenetics wishes you a wonderful Festive Season and [...]
1112, 2024
Diatech Pharmacogenetics will atten the 26th “Bamberger Morphologietage” Congress from January 24 to 26
Diatech Pharmacogenetics will attend the 26. Bamberger Morphologietagen From [...]
1911, 2024
Diatech Pharmacogenetics willl attend the XIII Molecular Cytopathology of Naples – December 9-10, 2024
This International Congress, started as a niche focus in [...]
1911, 2024
Diatech Pharmacogenetics will attend the Pathologists in Venice Congress – December 12 -13, 2024
Pathological diagnoses are becoming a very complicated medical field [...]